Thromboelastometry Predicts Thromboembolic Events, Hospital Length of Stay, and Mortality in Patients with COVID-19 Infection and Mild Hypoxemia: A Prospective Observational Study

References

• CDC. COVID-19 Mortality Overview; 2022. Available from: https://www.cdc.gov/nchs/covid19/mortality-overview.htm. Accessed May 13, 2022.
   Google Scholar
• Görlinger K, Levy JH. COVID-19-associated coagulopathy. Anesthesiology. 2021;134(3):366–369. doi:10.1097/ALN.0000000000003688
   PubMed Web of Science ®Google Scholar
• Zhan H, Chen H, Liu C, et al. Diagnostic value of D-dimer in COVID-19: a meta-analysis and meta-regression. Clin Appl Thromb Hemost. 2021;27:10760296211010976. doi:10.1177/10760296211010976
   Web of Science ®Google Scholar
• Govil D, Pal D. Point-of-care testing of coagulation in intensive care unit: role of thromboelastography. Indian J Crit Care Med. 2019;23(Suppl 3):S202–S206. doi:10.5005/jp-journals-10071-23253
   PubMed Web of Science ®Google Scholar
• Shen L, Tabaie S, Ivascu N. Viscoelastic testing inside and beyond the operating room. J Thorac Dis. 2017;9(Suppl 4):S299–S308. doi:10.21037/jtd.2017.03.85
   PubMed Web of Science ®Google Scholar
• Kruse JM, Magomedov A, Kurreck A, et al. Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis. Crit Care. 2020;24(1):676. doi:10.1186/s13054-020-03401-8
   PubMed Web of Science ®Google Scholar
• Creel-Bulos C, Auld SC, Caridi-Scheible M, et al. Fibrinolysis shutdown and thrombosis in a COVID-19 ICU. Shock. 2021;55(3):316–320. doi:10.1097/SHK.0000000000001635
   PubMed Web of Science ®Google Scholar
• Almskog LM, Wikman A, Svensson J, et al. Rotational thromboelastometry results are associated with care level in COVID-19. J Thromb Thrombolysis. 2021;51(2):437–445. doi:10.1007/s11239-020-02312-3
   PubMed Web of Science ®Google Scholar
• Herrmann J, Notz Q, Schlesinger T, et al. Point of care diagnostic of hypercoagulability and platelet function in COVID-19 induced acute respiratory distress syndrome: a retrospective observational study. Thromb J. 2021;19(1):39. doi:10.1186/s12959-021-00293-8
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int. J. Surg. 2014;12(12):1495–1499. doi:10.1016/j.ijsu.2014.07.013
   PubMed Web of Science ®Google Scholar
• Meltzer ME, Lisman T, de Groot PG, et al. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. Blood. 2010;116(1):113–121. doi:10.1182/blood-2010-02-267740
   PubMed Web of Science ®Google Scholar
• Chaurasia SN, Kushwaha G, Kulkarni PP, et al. Platelet HIF-2α promotes thrombogenicity through PAI-1 synthesis and extracellular vesicle release. Haematologica. 2019;104(12):2482–2492. doi:10.3324/haematol.2019.217463
   PubMed Web of Science ®Google Scholar
• Huebner BR, Moore EE, Moore HB, et al. Thrombin provokes degranulation of platelet α-granules leading to the release of active plasminogen activator inhibitor-1 (PAI-1). Shock. 2018;50(6):671–676. doi:10.1097/SHK.0000000000001089
   PubMed Web of Science ®Google Scholar
• Sørensen B, Johansen P, Christiansen K, Woelke M, Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost. 2003;1(3):551–558. doi:10.1046/j.1538-7836.2003.00075.x
   PubMed Web of Science ®Google Scholar
• Tafur LA, Taura P, Blasi A, et al. Rotation thromboelastometry velocity curve predicts blood loss during liver transplantation. Br J Anaesth. 2016;117(6):741–748. doi:10.1093/bja/aew344
   PubMed Web of Science ®Google Scholar
• Nougier C, Benoit R, Simon M, et al. Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis. J Thromb Haemost. 2020;18(9):2215–2219. doi:10.1111/jth.15016
   PubMed Web of Science ®Google Scholar
• Del Valle DM, Kim-Schulze S, Huang HH, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26:1636–1643. doi:10.1038/s41591-020-1051-9
   PubMed Web of Science ®Google Scholar
• Campbell RA, Hisada Y, Denorme F, et al. Comparison of the coagulopathies associated with COVID-19 and sepsis. Res Pract Thromb Haemost. 2021;5(4):e12525. doi:10.1002/rth2.12525
   PubMed Web of Science ®Google Scholar
• Juneja GK, Castelo M, Yeh CH, et al. Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: a single-center prospective longitudinal study. J Thromb Haemost. 2021;19(6):1546–1557. doi:10.1111/jth.15327
   PubMed Web of Science ®Google Scholar
• von Meijenfeldt FA, Havervall S, Adelmeijer J, et al. COVID-19 is associated with an acquired factor XIII deficiency. Thromb Haemost. 2021;121(12):1668–1669. doi:10.1055/a-1450-8414
   PubMed Web of Science ®Google Scholar
• Yin S, Huang M, Li D, Tang N. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. J Thromb Thrombolysis. 2020;51:1–4.
   Google Scholar
• Ranucci M, Ballotta A, Di Dedda U, et al. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost. 2020;18:1747–1751. doi:10.1111/jth.14854
   PubMed Web of Science ®Google Scholar
• Arcanjo A, Logullo J, Menezes CCB, et al. The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19). Sci Rep. 2020;10:19630. doi:10.1038/s41598-020-76781-0
   PubMed Web of Science ®Google Scholar
• Heinz C, Miesbach W, Herrmann E, et al. Greater fibrinolysis resistance but no greater platelet aggregation in critically Ill COVID-19 patients. Anesthesiology. 2021;134(3):457–467. doi:10.1097/ALN.0000000000003685
   PubMed Web of Science ®Google Scholar
• Bachler M, Bösch J, Stürzel DP, et al. Impaired fibrinolysis in critically ill COVID-19 patients. Br J Anaesth. 2021;126(3):590–598. doi:10.1016/j.bja.2020.12.010
   PubMed Web of Science ®Google Scholar
• Corrêa TD, Cordioli RL, Campos Guerra JC, et al. Coagulation profile of COVID-19 patients admitted to the ICU: an exploratory study. PLoS One. 2020;15(12):e0243604. doi:10.1371/journal.pone.0243604
   PubMed Web of Science ®Google Scholar
• Mei ZW, van Wijk XMR, Pham HP, Marin MJ. Role of von Willebrand factor in COVID-19 associated coagulopathy. J Appl Lab Med. 2021;6(5):1305–1315. doi:10.1093/jalm/jfab042
   PubMedGoogle Scholar
• Aires RB, Soares AASM, Gomides APM, et al. Thromboelastometry demonstrates endogenous coagulation activation in nonsevere and severe COVID-19 patients and has applicability as a decision algorithm for intervention. PLoS One. 2022;17(1):e0262600. doi:10.1371/journal.pone.0262600
   PubMed Web of Science ®Google Scholar
• Choi JK, Prabhakaran K, Latifi R, et al. Serial rotational thromboelastography (ROTEM) in mechanically ventilated patients with COVID-19 demonstrates hypercoagulopathy despite therapeutic heparinization. Trauma Surg Acute Care Open. 2022;7(1):e000603. doi:10.1136/tsaco-2020-000603
   PubMedGoogle Scholar
• Fan BE, Ramanathan K, Sum CLL, et al. Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study. J Thromb Thrombolysis. 2022;53(3):646–662. doi:10.1007/s11239-021-02575-4
   PubMed Web of Science ®Google Scholar
• REMAP-CAP Investigators; ACTIV-4a Investigators; ATTACC Investigators. Therapeutic anticoagulation with heparin in critically ill patients with COVID-19. N Engl J Med. 2021;385:777–789.
   PubMed Web of Science ®Google Scholar
• Chaudhary R, Kreutz RP, Bliden KP, Tantry US, Gurbel PA. Personalizing antithrombotic therapy in COVID-19: role of thromboelastography and thromboelastometry. Thromb Haemost. 2020;120(11):1594–1596. doi:10.1055/s-0040-1714217
   PubMed Web of Science ®Google Scholar
• Fox SE, Akmatbekov A, Harbert JL, Li G, Quincy Brown J, Vander Heide RS. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir Med. 2020;8:681–686. doi:10.1016/S2213-2600(20)30243-5
   PubMed Web of Science ®Google Scholar
• Fogarty H, Townsend L, Ni Cheallaigh C, et al. COVID19 coagulopathy in Caucasian patients. Br J Haematol. 2020;189:1044–1049. doi:10.1111/bjh.16749
   PubMed Web of Science ®Google Scholar
• Kim SJ, Bostwick W. Social vulnerability, and racial inequality in COVID-19 deaths in Chicago. Health Educ Behav. 2020;47:509–513. doi:10.1177/1090198120929677
   PubMed Web of Science ®Google Scholar